The Effectiveness, Tolerability, and Safety of Different 1-Day Bowel Preparation Regimens for Pediatric Colonoscopy

Table 3

Patient acceptability questionnaire.

Variable	PEG-bisacodyl group,	PEG-ELS group,	NaPico+MgCit group,	All groups,
Ease of taking
No distress	11 (26.8%)	7 (16.3%)	23 (59.0%)	41 (33.3%)
Mild difficulty	9 (23%)	14 (32.6%)	8 (20.5%)	31 (25.2%)	NS
Moderate difficulty	10 (24.4%)	11 (25.6%)	5 (12.8%)	26 (21.1%)	NS
Great difficulty	11 (26.8%)	11 (25.6%)	4 (10.3%)	26 (21.1)	NS
Poor acceptance of taste	13 (31.7%)	16 (37.2%)	2 (5.1%)	31 (25.2%)
High volume	10 (24.4%)	21 (56.8%)	2 (5.1%)	33 (28.2%)
Whole volume intake	36 (87.8%)	32 (74.4%)	37 (94.9%)	105 (85.4%)	^±
Willingness to repeat	25 (61.0%)	16 (37.2%)	33 (84.6%)	74 (60.2%)	^±±

NS = statistically nonsignificant; PEG-bisacodyl vs. PEG-ELS: , PEG-bisacodyl vs. NaPico+MgCit: , and PEG-ELS vs. NaPico+MgCit: ; PEG-bisacodyl vs. PEG-ELS: , PEG-bisacodyl vs. NaPico+MgCit: , and PEG-ELS vs. NaPico+MgCit: ; PEG-bisacodyl vs. PEG-ELS: , PEG-bisacodyl vs. NaPico+MgCit: , and PEG-ELS vs. NaPico+MgCit: ; ^±PEG-bisacodyl vs. PEG-ELS: , PEG-bisacodyl vs. NaPico+MgCit: , and PEG-ELS vs. NaPico+MgCit: ; ^±±PEG-bisacodyl vs. PEG-ELS: , PEG-bisacodyl vs. NaPico+MgCit: , and PEG-ELS vs. NaPico+MgCit: .